Pacific Edge Limited (PFGTF) has released an update.
Pacific Edge Limited, a New Zealand-based leader in cancer diagnostics, has announced its Annual Shareholder Meeting to be held on 24 September 2024, with a director nomination deadline set for 30 July 2024. Shareholders are entitled to nominate directors and need to submit their nominations by the stipulated deadline. The company, known for its innovative Cxbladder tests used in bladder cancer detection and management, will provide further details to its shareholders in an upcoming Notice of Meeting.
For further insights into PFGTF stock, check out TipRanks’ Stock Analysis page.
